Pub. Date : 2010 Nov 26
PMID : 21108851
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Dasatinib and nilotinib, two newer drugs with higher potency than imatinib against BCR-ABL and activity against most imatinib-resistant BCR-ABL mutations, have each shown superior efficacy compared with imatinib for first-line treatment of chronic-phase CML in randomized phase 3 trials. | Dasatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |
| 2 | Dasatinib and nilotinib, two newer drugs with higher potency than imatinib against BCR-ABL and activity against most imatinib-resistant BCR-ABL mutations, have each shown superior efficacy compared with imatinib for first-line treatment of chronic-phase CML in randomized phase 3 trials. | Dasatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |